105 related articles for article (PubMed ID: 9315080)
1. Borrelidin is an angiogenesis inhibitor; disruption of angiogenic capillary vessels in a rat aorta matrix culture model.
Wakabayashi T; Kageyama R; Naruse N; Tsukahara N; Funahashi Y; Kitoh K; Watanabe Y
J Antibiot (Tokyo); 1997 Aug; 50(8):671-6. PubMed ID: 9315080
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenesis effects of borrelidin are mediated through distinct pathways: threonyl-tRNA synthetase and caspases are independently involved in suppression of proliferation and induction of apoptosis in endothelial cells.
Kawamura T; Liu D; Towle MJ; Kageyama R; Tsukahara N; Wakabayashi T; Littlefield BA
J Antibiot (Tokyo); 2003 Aug; 56(8):709-15. PubMed ID: 14563161
[TBL] [Abstract][Full Text] [Related]
3. Luminacins: a family of capillary tube formation inhibitors from Streptomyces sp. II. Biological activities.
Wakabayashi T; Kageyama-Kawase R; Naruse N; Funahashi Y; Yoshimatsu K
J Antibiot (Tokyo); 2000 Jun; 53(6):591-6. PubMed ID: 10966074
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor.
Morais C; Gobe G; Johnson DW; Healy H
Angiogenesis; 2009; 12(4):365-79. PubMed ID: 19882112
[TBL] [Abstract][Full Text] [Related]
5. Media conditioned by smooth muscle cells cultured in a variety of hypoxic environments stimulates in vitro angiogenesis. A relationship to transforming growth factor-beta 1.
Sakuda H; Nakashima Y; Kuriyama S; Sueishi K
Am J Pathol; 1992 Dec; 141(6):1507-16. PubMed ID: 1281623
[TBL] [Abstract][Full Text] [Related]
6. Borrelidins F-I, cytotoxic and cell migration inhibiting agents from mangrove-derived Streptomyces rochei SCSIO ZJ89.
Sun J; Shao J; Sun C; Song Y; Li Q; Lu L; Hu Y; Gui C; Zhang H; Ju J
Bioorg Med Chem; 2018 May; 26(8):1488-1494. PubMed ID: 29452840
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats.
Zhang D; Kaufman PL; Gao G; Saunders RA; Ma JX
Diabetologia; 2001 Jun; 44(6):757-65. PubMed ID: 11440369
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of angiogenic factor- and tumour-induced angiogenesis by gamma linolenic acid.
Cai J; Jiang WG; Mansel RE
Prostaglandins Leukot Essent Fatty Acids; 1999 Jan; 60(1):21-9. PubMed ID: 10319914
[TBL] [Abstract][Full Text] [Related]
9. Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathway.
Bauer KS; Cude KJ; Dixon SC; Kruger EA; Figg WD
J Pharmacol Exp Ther; 2000 Jan; 292(1):31-7. PubMed ID: 10604929
[TBL] [Abstract][Full Text] [Related]
10. Vernolide-A inhibits tumour specific angiogenesis by regulating proinflammatory cytokines, VEGF, MMPs and TIMP.
Pratheeshkumar P; Kuttan G
Eur J Pharmacol; 2011 Apr; 656(1-3):10-8. PubMed ID: 21256125
[TBL] [Abstract][Full Text] [Related]
11. Characterization of rat aortic fragment within collagen gel as an angiogenesis model; capillary morphology may reflect the action mechanisms of angiogenesis inhibitors.
Hata-Sugi N; Kawase-Kageyama R; Wakabayashi T
Biol Pharm Bull; 2002 Apr; 25(4):446-51. PubMed ID: 11995922
[TBL] [Abstract][Full Text] [Related]
12. Induction of aerial mycelium formation in a bld mutant of Streptomyces tendae by borrelidin--a macrolide antibiotic.
Schüz TC; Zähner H
FEMS Microbiol Lett; 1993 Nov; 114(1):41-5. PubMed ID: 8293958
[TBL] [Abstract][Full Text] [Related]
13. Tetraarsenic oxide, a novel orally administrable angiogenesis inhibitor.
Park MJ; Park IC; Bae IJ; Seo KM; Lee SH; Hong SI; Eun CK; Zhang W; Rhee CH
Int J Oncol; 2003 Jun; 22(6):1271-6. PubMed ID: 12738993
[TBL] [Abstract][Full Text] [Related]
14. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.
McCollum GW; Rajaratnam VS; Bullard LE; Yang R; Penn JS
Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of angiogenesis by interleukin-4 gene therapy in rat adjuvant-induced arthritis.
Haas CS; Amin MA; Allen BB; Ruth JH; Haines GK; Woods JM; Koch AE
Arthritis Rheum; 2006 Aug; 54(8):2402-14. PubMed ID: 16869003
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tumor angiogenesis by roxithromycin, a 14-membered ring macrolide antibiotic.
Yatsunami J; Tsuruta N; Hara N; Hayashi S
Cancer Lett; 1998 Sep; 131(2):137-43. PubMed ID: 9851245
[TBL] [Abstract][Full Text] [Related]
17. Piper longum inhibits VEGF and proinflammatory cytokines and tumor-induced angiogenesis in C57BL/6 mice.
Sunila ES; Kuttan G
Int Immunopharmacol; 2006 May; 6(5):733-41. PubMed ID: 16546703
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo.
Lobov IB; Brooks PC; Lang RA
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11205-10. PubMed ID: 12163646
[TBL] [Abstract][Full Text] [Related]
19. The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo.
Yeh JC; Cindrova-Davies T; Belleri M; Morbidelli L; Miller N; Cho CW; Chan K; Wang YT; Luo GA; Ziche M; Presta M; Charnock-Jones DS; Fan TP
Angiogenesis; 2011 May; 14(2):187-97. PubMed ID: 21327473
[TBL] [Abstract][Full Text] [Related]
20. In vitro assay of angiogenesis: inhibition of capillary tube formation.
McGonigle S; Shifrin V
Curr Protoc Pharmacol; 2008 Dec; Chapter 12():Unit12.12. PubMed ID: 22294219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
